Combining health data with whole genome sequence data in cancer patients can help doctors provide more tailored care

Researchers evaluated the impact of integrating whole-genome sequencing data with clinical outcomes across 13,880 tumors from 33 cancer types, assessing precision care potentials within the UK NHS through the 100,000 Genomes Cancer Programme.

AAVantgarde closes €61M financing to move gene delivery program to the clinic

AAVantgarde Bio, a clinical-stage, Italian-based international biotechnology company with two proprietary adeno-associated viral (AAV) vector platforms for large gene delivery, has closed a €61 million

June 7, 2023

NJ judge tosses Novartis’ IRA lawsuit in another win for government

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 19, 2024

FDA confirms end of Eli Lilly’s tirzepatide shortage after re-evaluation – Pharmaceutical Technology

The FDA declared the tirzepatide shortage over in October 2023, but reconsidered its decision following litigation by a compounding trade group. Image credit: GettyImages/ Scott

December 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.